As of 2024-12-15, the Intrinsic Value of MEI Pharma Inc (MEIP) is
24.13 USD. This MEIP valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 2.70 USD, the upside of MEI Pharma Inc is
793.80%.
The range of the Intrinsic Value is 18.35 - 36.12 USD
24.13 USD
Intrinsic Value
MEIP Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
18.35 - 36.12 |
24.13 |
793.8% |
| DCF (Growth 10y) |
21.52 - 42.26 |
28.30 |
948.1% |
| DCF (EBITDA 5y) |
27.14 - 39.25 |
33.87 |
1154.5% |
| DCF (EBITDA 10y) |
28.16 - 44.35 |
36.22 |
1241.6% |
| Fair Value |
-34.99 - -34.99 |
-34.99 |
-1,395.82% |
| P/E |
(192.85) - 62.11 |
(100.59) |
-3825.6% |
| EV/EBITDA |
(63.28) - 36.86 |
(20.34) |
-853.2% |
| EPV |
(32.96) - (56.70) |
(44.83) |
-1760.3% |
| DDM - Stable |
(32.41) - (99.03) |
(65.72) |
-2534.1% |
| DDM - Multi |
9.85 - 27.05 |
14.85 |
450.1% |
MEIP Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
17.98 |
| Beta |
-0.35 |
| Outstanding shares (mil) |
6.66 |
| Enterprise Value (mil) |
11.03 |
| Market risk premium |
4.60% |
| Cost of Equity |
11.24% |
| Cost of Debt |
5.00% |
| WACC |
7.45% |